National Pension Service Has $2.78 Million Stake in The Clorox Company $CLX

National Pension Service boosted its position in The Clorox Company (NYSE:CLX) by 68.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,537 shares of the company’s stock after buying an additional 11,233 shares during the period. National Pension Service’s holdings in Clorox were worth $2,777,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of CLX. Van ECK Associates Corp lifted its holdings in Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after buying an additional 1,312,471 shares during the period. Invesco Ltd. lifted its holdings in Clorox by 23.1% in the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after buying an additional 750,415 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in Clorox by 6,907.9% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock valued at $75,593,000 after buying an additional 739,005 shares during the period. Worldquant Millennium Advisors LLC acquired a new position in Clorox in the second quarter valued at $71,856,000. Finally, Two Sigma Investments LP lifted its holdings in Clorox by 33.8% in the third quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after buying an additional 439,797 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Down 1.0%

Clorox stock opened at $89.10 on Tuesday. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03. The firm has a market capitalization of $10.77 billion, a price-to-earnings ratio of 14.46, a price-to-earnings-growth ratio of 0.47 and a beta of 0.59. The firm’s fifty day moving average price is $98.11 and its two-hundred day moving average price is $105.71. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue for the quarter was up .1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts predict that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. The Goldman Sachs Group restated a “sell” rating and issued a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research note on Friday, February 13th. Finally, BNP Paribas Exane decreased their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company. According to MarketBeat, Clorox currently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.63% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.